Loading…
Lucid Diagnostics Inc. is projected to rise to $0.9174 by 2027, a +5% move from its current price of $0.8716. LUCD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $0.8411 | $0.871 | $0.902 | -0.07% |
| Aug 5 | $0.8284 | $0.8704 | $0.9145 | -0.14% |
| Aug 6 | $0.8187 | $0.8698 | $0.9241 | -0.21% |
| Aug 7 | $0.8105 | $0.8692 | $0.9322 | -0.27% |
| Aug 8 | $0.8033 | $0.8686 | $0.9392 | -0.34% |
| Aug 9 | $0.7968 | $0.868 | $0.9456 | -0.41% |
| Aug 10 | $0.7908 | $0.8674 | $0.9515 | -0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7908 | $0.8674 | $0.9515 | -0.48% |
| Week 2 | $0.7574 | $0.8633 | $0.9839 | -0.96% |
| Week 3 | $0.732 | $0.8591 | $1.01 | -1.43% |
| Week 4 | $0.7106 | $0.855 | $1.03 | -1.90% |
| Week 5 | $0.6919 | $0.8509 | $1.05 | -2.37% |
| Week 6 | $0.6752 | $0.8468 | $1.06 | -2.84% |
| Week 7 | $0.6598 | $0.8428 | $1.08 | -3.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma.
The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc.
operates as a subsidiary of PAVmed Inc.
Lucid Diagnostics Inc. (LUCD) is a healthcare stock with a current price of $0.9076 and a market capitalization of $173.14M. It is ranked 3685 by market cap.
A major floor 21.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 31.9% above — a clean break opens room to run.
A major ceiling 61.8% above — clearing it would confirm fresh momentum.
Key LUCD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LUCD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.9018 | Sell | $0.9012 | Sell |
| MA 10 | $0.9244 | Sell | $0.9245 | Sell |
| MA 20 | $0.9709 | Sell | $0.9561 | Sell |
| MA 50 | $1.00 | Sell | $1.01 | Sell |
| MA 100 | $1.09 | Sell | $1.06 | Sell |
| MA 200 | $1.14 | Sell | $1.10 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.89 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -134.89 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -24.17 | Sell |
| Bollinger %B (20,2) | 0.12 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.35 | Sell |
| Awesome (5,34) | -0.10 | Sell |
| Ultimate (7,14,28) | 25.81 | Buy |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 0.89 | Sell |
| ADX (14) | 14.61 | Neutral |
| ATR (14) | 0.03 | Info |
The near-term picture for LUCD is bearish overall. RSI14 is 40, and the stock trades below two common moving averages: SMA50 at $1.01 and SMA200 at $1.14, suggesting limited upside momentum in the immediate window.
Key support sits at $0.908 and resistance at $1.15, helping to cap price action. The 30-day range runs from a low of $0.6988 to a high of $1.18, reflecting a relatively tight trading band with notable volatility. The annualized volatility is 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.8716 | $0.8716 | $1.08 | 0% | Neutral | |
| $0.7132 | $0.9174 | $1.26 | +5% | Neutral | |
| $0.7072 | $0.9443 | $1.36 | +8% | Neutral | |
| $0.6766 | $0.932 | $1.39 | +7% | Neutral | |
| $0.7184 | $1.02 | $1.56 | +17% | Neutral | |
| $0.8513 | $1.24 | $1.95 | +42% | Bullish | |
| $1.02 | $1.52 | $2.44 | +74% | Bullish | |
| $1.01 | $1.54 | $2.53 | +76% | Bullish | |
| $0.9792 | $1.52 | $2.55 | +74% | Bullish | |
| $1.06 | $1.68 | $2.87 | +93% | Bullish | |
| $1.50 | $2.61 | $4.79 | +199% | Bullish | |
| $1.85 | $3.81 | $7.77 | +337% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.8716 | $0.8716 | $1.07 | +0.00% |
| September 2026 | $0.7093 | $0.8457 | $1.04 | -2.97% |
| October 2026 | $0.6807 | $0.8187 | $1.02 | -3.19% |
| November 2026 | $0.6932 | $0.8398 | $1.06 | +2.57% |
| December 2026 | $0.6953 | $0.848 | $1.08 | +0.97% |
Click any year to see its month-by-month LUCD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Lucid Diagnostics Inc.'s 2026 outlook centres on $0.8716, within a $0.8716 to $1.08 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, LUCD could reach as high as $1.26, with a base case around $0.9174 and support toward $0.7132 — roughly +5% from $0.8716. Price action looks broadly range-bound.
Expect LUCD to range from $0.7072 to $1.36 through 2028. The $0.9443 average target implies a +8% move from current prices. That is up +3% on the projected 2027 average. A consolidation phase looks the most probable path here.
The LUCD price prediction for 2029 points to an average of $0.932 (low $0.6766, high $1.39) — a potential gain of +7% on today's $0.8716. Price action looks broadly range-bound.
In 2030, LUCD is projected to trade between $0.7184 and $1.56, averaging $1.02 — a potential gain of +17% from today's $0.8716. That is up +9% on the projected 2029 average. A consolidation phase looks the most probable path here.
Lucid Diagnostics Inc.'s 2031 outlook centres on $1.24, within a $0.8513 to $1.95 range. That is up +22% on the projected 2030 average. That marks a +42% change versus current levels. Momentum favours further upside here.
By 2032, LUCD could reach as high as $2.44, with a base case around $1.52 and support toward $1.02 — roughly +74% from $0.8716. Buyers look set to stay in control over this stretch.
Expect LUCD to range from $1.01 to $2.53 through 2033. The $1.54 average target implies a +76% move from current prices. That is up +1% on the projected 2032 average. Momentum favours further upside here.
The LUCD price prediction for 2034 points to an average of $1.52 (low $0.9792, high $2.55) — a potential gain of +74% on today's $0.8716. Buyers look set to stay in control over this stretch.
In 2035, LUCD is projected to trade between $1.06 and $2.87, averaging $1.68 — a potential gain of +93% from today's $0.8716. That is up +11% on the projected 2034 average. Momentum favours further upside here.
Lucid Diagnostics Inc.'s 2040 outlook centres on $2.61, within a $1.50 to $4.79 range. That is up +55% on the projected 2035 average. That marks a +199% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, LUCD could reach as high as $7.77, with a base case around $3.81 and support toward $1.85 — roughly +337% from $0.8716. Momentum favours further upside here.
Investing $1,000 in LUCD today (≈ 1,147.315282 LUCD) could be worth
$4,367.22
+$3,367.22 (+337%) by 2050 · US Dollar
Based on the average projected LUCD price of $3.81 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LUCDwould be worth at today's price.
$1,000 invested in LUCD on Jul 31, 2025 (≈ 1,021.450489 LUCD) would be worth
$890.3
-$109.7 (-11.0%) today · 0.89× · US Dollar
Based on a LUCD entry price of $0.979 vs. today's $0.8716.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.908 | $959.91 | -4.0% |
| 1 month ago | $1.05 | $830.1 | -17.0% |
| 3 months ago | $1.09 | $799.63 | -20.0% |
| 6 months ago | $1.28 | $680.94 | -31.9% |
| 1 year ago | $0.979 | $890.3 | -11.0% |
| All time (4.8y) ago | $11.76 | $74.12 | -92.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LUCD forecast.
Our base-case forecast reaches $1.70 around 2040.
Implied market cap at $1.70: $324.31M
The multi-year forecast shows a cautious start followed by meaningful upside later in the period. In 2026 the min and avg prices are both $0.9076 with a max of $1.12 and ROI of 0%, indicating a neutral stance. By 2031 the average price rises to $1.24 with a max of $2.02 and ROI of 36.4%, signaling a bullish shift.
The trajectory continues with 2032 at $1.49 (max $2.49, ROI 63.9%), 2033 at $1.52 (max $2.60, ROI 67.4%), 2034 at $1.50 (max $2.63, ROI 65.7%), and 2035 at $1.62 (max $2.89, ROI 78.7%). In 2040 the forecast shows a strong move higher to an average price of $2.55 with a max of $4.91 and ROI of 180.4%, and the sentiment remains BULLISH. By 2050 the average price is seen at $3.50 with a max of $7.55 and ROI of 285.5%, continuing the bullish stance.
Tap a question to reveal the answer.
2030 min $0.6812; avg $0.9963; max $1.58; ROI 9.8%; sentiment NEUTRAL.
Forecasts show neutral conditions in 2026 (min $0.9076, avg $0.9076, max $1.12, ROI 0, sentiment NEUTRAL) with a bullish shift beginning in 2031 (2031 avg $1.24, max $2.02, ROI 36.4). Long-range outlook includes strong upside by 2040 (avg $2.55, max $4.91, ROI 180.4) and by 2050 (avg $3.50, max $7.55, ROI 285.5). These are estimates, not guarantees.
Yes. The 2032 forecast shows a max of $2.49 and an average of $1.49 (min $0.9607; ROI 63.9), with bullish sentiment.
2040 forecast: min $1.36; avg $2.55; max $4.91; ROI 180.4; sentiment BULLISH.
Current price $0.9076; Market cap $173.14M.
Lucid Diagnostics Inc. Community Discussion
0Share your Lucid Diagnostics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.